Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Evans syndrome is a rare chronic hematologic disorder characterized by the simultaneous or sequential association of autoimmune hemolytic anemia (AIHA; a disorder in which auto-antibodies are directed against red blood cells causing anemia of varying degrees of severity) with immune thrombocytopenic purpura (ITP; a coagulation disorder in which auto-antibodies are directed against platelets causing hemorrhagic episodes) and occasionally autoimmune neutropenia, in the absence of a known underlying etiology.
Biomarker and diagnostic research for Evans syndrome has been reported in the published literature.
Estimated prevalence: 1-9 in 1,000,000 (Rare).
7 clinical trials registered, 6 recruiting. Interventions under study include drug therapy, biologic therapy, and other interventions. Pipeline includes 4 PHASE2, 1 PHASE1, 1 EARLY_PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT07441525](https://clinicaltrials.gov/study/NCT07441525) |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 2:11 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Evans syndrome
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases |
EARLY_PHASE1 |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
RECRUITING |
[NCT04915482](https://clinicaltrials.gov/study/NCT04915482) | TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies | PHASE2 | Institute of Hematology & Blood Diseases Hospital, China | UNKNOWN |
[NCT07175493](https://clinicaltrials.gov/study/NCT07175493) | A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia | PHASE1 | Keymed Biosciences Co.Ltd | RECRUITING |
[NCT07421167](https://clinicaltrials.gov/study/NCT07421167) | A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) | PHASE2 | Novartis Pharmaceuticals | RECRUITING |
[NCT06014775](https://clinicaltrials.gov/study/NCT06014775) | Anti-CD38 Antibody Treating Evans Syndrome | PHASE2 | Institute of Hematology & Blood Diseases Hospital, China | RECRUITING |
171 publications have been identified in PubMed for Evans syndrome. Research spans Case Report / Case Series (45%), Review / Meta-Analysis (23%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 77 | 45% |
Research summaries | 39 | 23% |
Disease patterns and progression | 22 | 13% |
Laboratory research | 11 | 6% |
Clinical study results | 10 | 6% |
Testing and diagnosis research | 7 | 4% |
New treatment approaches | 3 | 2% |
Other research | 2 | 1% |
Korte IK (2026). [PMID: 41962541](https://pubmed.ncbi.nlm.nih.gov/41962541/). *Med*. [Case Report / Case Series]
Hu N (2026). [PMID: 41577641](https://pubmed.ncbi.nlm.nih.gov/41577641/). *Thoracic cancer*. [Case Report / Case Series]
Wei CY (2026). [PMID: 41822507](https://pubmed.ncbi.nlm.nih.gov/41822507/). *Frontiers in immunology*. [Case Report / Case Series]
Kim TO (2026). [PMID: 41816818](https://pubmed.ncbi.nlm.nih.gov/41816818/). *Haematologica*. [Diagnostic / Biomarker]
Yamaguchi Y (2026). [PMID: 42270395](https://pubmed.ncbi.nlm.nih.gov/42270395/). *Intern Med*. [Case Report / Case Series]
Janson M (2026). [PMID: 41905276](https://pubmed.ncbi.nlm.nih.gov/41905276/). *Cancer Treat Rev*. [Review / Meta-Analysis]
Pitaro AT (2026). [PMID: 42255844](https://pubmed.ncbi.nlm.nih.gov/42255844/). *Cureus*. [Case Report / Case Series]
Aladjidi N (2026). [PMID: 42262305](https://pubmed.ncbi.nlm.nih.gov/42262305/). *Br J Haematol*. [Epidemiology / Natural History]
Röth A (2026). [PMID: 41366634](https://pubmed.ncbi.nlm.nih.gov/41366634/). *Am J Hematol*. [Clinical Trial Publication]
Maruta M (2026). [PMID: 42037796](https://pubmed.ncbi.nlm.nih.gov/42037796/). *Cureus*. [Case Report / Case Series]
AI-curated news mentioning Evans syndrome
Updated Aug 21, 2026
A case report highlights the occurrence of Epstein-Barr virus (EBV) induced Evans syndrome in a patient with systemic lupus erythematosus (SLE) related macrophage activation syndrome (MAS). This finding contributes to the understanding of the interplay between viral infections and autoimmune conditions.